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Although  it  is agreed  that  mononuclear cells,  especially T  lymphocytes, have an 
essential role in the rejection of vascularized grafts in previously unsensitized, geneti- 
cally  incompatible hosts  (i.e.,  first-set  set  allografts)  (1-10),  it  is  not  yet  clear how 
inflammatory cells or  their products  actually  effect graft destruction.  One  popular 
view, originating  with  the classic studies  of Medawar  (1)  and  supported  by many 
subsequent  authors  (2,  7,  11), holds that the epithelial elements of the graft bear the 
brunt of the immune response and are destroyed by an invasive-destructive infiltration 
of inflammatory cells. Such a concept is supported by in vitro studies demonstrating 
that  lymphocytes, macrophages, and perhaps, granulocytes are able to destroy indi- 
vidual epithelial  target cells either by direct cell contact or by secretion of cytotoxic 
mediators (12-18). 
An alternate possibility suggests that the host's immune response is directed at least 
in part against the blood vessels of the graft which are thought to share histocompat- 
ibility antigens with epithelial cells (4, 6,  10,  19-22). According to this view, allografts 
are rejected  as a  direct  consequence of vascular occlusion  and  tissue ischemia. This 
hypothesis  is  supported  by the  observation  of intimal  thickening  and  lymphocytic 
infiltration  of  major  graft  vessels  in  the  course  of  renal  (21),  cardiac  (23),  and 
pulmonary (24)  transplant rejection and by recent histochemical evidence describing 
loss of ATPase activity in the vessels of rejecting renal allografts (25).  However, other 
morphologic  evidence of vascular  injury  in  cell-mediated  allograft  rejection  is  less 
secure. Some authors have described widespread vascular thrombosis in skin-allograft 
rejection (19,  22) and from this have inferred a preceding endothelial lesion, but most 
investigators regard vascular thrombosis as a  late and sporadic event in the rejection 
process. In addition to infiltration of the epithelium by mononuclear cells, Waksman 
(4)  reported damage to both arteries and veins as well as "mononuclear cell throm- 
bosis"  in  rat  skin  allograft  rejection.  However,  these  studies  taxed  the  limits  of 
conventional light microscopy and were not supported by subsequent electron micro- 
scope studies  in  the  rabbit  (1 1).  In  view of these  contradictions,  a  predominantly 
vascular mechanism for the cell-mediated rejection of first-set allografts has not gained 
wide acceptance. 
Having  recently  demonstrated  microvascular lesions  in  delayed  hypersensitivity 
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reactions  (26,  27),  we were  prompted  to reexamine the pathogenesis of first-set skin 
allograft rejection using morphologic techniques that permitted both extensive vessel 
sampling and  unequivocal  identification and  evaluation of vessel endothelial cells. 
We here report that widespread microvascular damage is indeed a  characteristic and 
early feature of the cellular immune response to first-set human skin allografts and is 
qualitatively similar to, but substantially more intense than, that occurring in delayed 
hypersensitivity reactions  (26,  27).  Microvascular damage  invariably preceded  evi- 
dence  of significant  epithelial  necrosis,  and  affected  initially and  primarily  those 
venules, arterioles, and small veins enveloped by lymphocytes and other inflammatory 
cells. These findings strongly suggest that endothelial cells of the microvasculature are 
the critical target of the immune response in first-set skin allograft rejection in man, 
and that rejection itself can be attributed largely to ischemic infarction resulting from 
extensive microvascular damage. 
Materials  and  Methods 
Skin Grafting Procedure.  The design and conduct of these experiments were approved by the 
Human  Studies Committee of the Massachusetts General Hospital. Volunteers were accepted 
only  after  the  results  of a  thorough  medical  history,  physical  examination,  and  routine 
laboratory tests proved to be within normal limits. 
Split-thickness thigh skin (~0.3-mm-thick) for use as allografts was removed with a derma- 
tome from one of the investigators and from another adult male volunteer, packed in sterile, 
saline-soaked gauze,  and  sutured  in  place on  prepared sites  (~2.5  ×  5  cm)  within  3  h  of 
removal.  Each  donor provided allografts for  four recipients. Split-thickness graft  beds were 
prepared by free-hand dissection on both deltoid surfaces of eight adult male volunteers under 
local anesthesia. Allografts were transplanted to both arms of each recipient. All grafts were 
covered with compression bandages except at times of examination and biopsy. 
Ideally, skin  would  also  have  been  removed  from  each  recipient with  a  dermatome  for 
reimplantation  as  an  autograft.  Because  this  was  impractical,  four  recipients  received  as 
autografts  the  skin  removed  during  preparation  of a  second  graft  bed  on  the  right  arm. 
However, free-hand dissected autografts were approximately three times thicker than derma- 
tome-prepared allografts, and we were concerned  that  these thicker grafts might experience 
difficulty acquiring a blood supply. For this reason, autografts for the first four recipients were 
freed from the graft bed beneath and on three sides but the fourth side (2.5-cm. dimension) was 
allowed to remain in continuity, thereby creating a skin flap which was sutured in place. 
Graft  Biopsy,  Tissue  Processtng and Human-Leukocyte-Antigen  (HLA) r  Typing.  Grafts were ex- 
amined and biopsied on day 3 or 4 and daily thereafter until day  12-13. Biopsies were taken 
with a 4-mm punch using 2% xylocaine without epinephrine. Tissue was fixed in paraformal- 
dehyde-glutaraldehyde for 5 h  at room temperature and was processed for giant,  1-/~m-thick 
Epon  (Shell  Chemical  Co.,  New  York)  sections  and  for  electron  microscopy as  previously 
described (26, 28). A total of t26 biopsies from allografts and 42 from autografts was studied in 
giant,  1-/~m-thick  Epon  sections.  One-half of these  were  additionally studied  by  electron 
microscopy and the other one-half by immunofluorescence. For the latter procedure, cryostat 
sections of fresh, frozen tissue were stained with specific fluoresceinated goat or rabbit antisera 
to human  fibrinogen/fibrin, polyvalent human  gamma globulin, C'3, and human  albumin, 
and  examined in a  Zeiss fluorescence microscope (Carl Zeiss, Inc., New  York)  as previously 
described (26). 
HLA typing and tests for development of anti-HLA antibodies in recipients were performed 
using published procedures (29, 30). 
Results 
At least three HLA  incompatibilities distinguished each  recipient  from  his donor 
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TABLE  I 
Blood Group and HLA Serotyping of Skin Allografi Donors and Recipients 
Donors  Recipients 
Num-  ABO- 
ber  Age  RhoD 
Day of 
rejec- 
HLA  Num-  ABO-  HLA  tion 
phenotype  ber  Age  RHoD  phenotype  (gross) 
Number 
of 
tILA-A 
and-B 
lOCUS 
incompati- 
bilities 
between 
donor/ 
recipient 
yr 
1  35  o+  A3, 10; B8, x*  1 
2 
2  38  0+  A3, 29; B7, 12 
yr 
34  A+  A2, 9; B7, 27  10-11  4 
32  B+  A9,  x;*  Bw35,  10  4 
40 
3  38  0+  A3, 29; B7, 12  11-12  3 
4  39  0 +  A 1, 2; B40, --  11  3-4 
5  55  B+  AI,  3;  B17,  --  12  3 
6  22  B+  A2, 9; B13, w35  11-12  4 
7  34  0+  A1, 2; B8,--  11-12  4 
8  34  0+  AI,2; B8, 12  11  3 
* x, undefined HLA alloantigen. 
(Table I). All recipients had a  negative cross match against donor lymphocytes at the 
time of grafting.  Moreover,  recipients  lacked detectable  cytotoxic antibodies  against 
donor lymphocytes at  7 and  15 d  after transplant. 
After initial  revascularization,  all  16 allografts were sloughed  between days  10 and 
12.  By contrast,  all autografts healed in place and survived indefinitely. 
Microscopic  Appearance of Allografts 
EARLY HEAUNO AND LEUKOCYTE INHLT~ATION.  Healing of allografts  proceeded  in 
accord  with  published  descriptions  (1-3,  7,  10,  II,  19).  In  brief,  blood  flow  was 
established  by 3-4 d  as judged  both by the clinical  appearance  of the  grafts and  by 
the presence of erythrocytes and plasma within small vessels at all levels of the dermis. 
Nonetheless,  the junction  between the graft  (tissue of donor origin)  and the graft bed 
(tissue  of recipient  origin)  could  be  positively  and  precisely  identified  through  the 
time  of graft  rejection.  This  interface  was  marked  by  (a)  trace  residual  deposits  of 
matted  fibrin, erythrocytes, and other debris dating  from the time of surgery  (Fig.  1) 
or (b) by proliferating epithelium,  derived  from transected  hair follicles, in the plane 
of the  graft-graft  bed  interface  (Fig.  2A).  As  early  as  day  5,  allografts  could  be 
differentiated  microscopically  from autografts  by the  appearance  of a  mononuclear 
cell infiltrate about nearly all venules and adjacent arterioles of deeper portions of the 
allograft  and  the subjacent  graft  bed  (Fig.  t,  levels 2-4;  Fig.  2A,  B).  Accumulating 
cells consisted largely (>90%) of small lymphocytes and lymphoblasts, the majority of 
which remained in close proximity to the venules from which they emigrated, forming 
the  perivenular  cuffs  characteristic  of delayed  hypersensitivity  reactions  (2,  7,  26). 
Monocytes and macrophages were represented  in these perivenular infiltrates in small 
numbers,  and plasma cells were observed only rarely. DVORAK,  MIHM,  DVORAK,  BARNES,  MANSEAU, AND GALLI 
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Fuc.  1.  Schematic diagram of skin allograft  rejection. The graft and graft  bed are separated by a 
thin layer of matted fibrin and debris which is bridged by blood vessels. Graft blood vessels of the 
papillary dermis (level I) are not enveloped by cuffs of lymphocytes, whereas deeper graft  vessels 
(level 2), as well as vessels of the graft bed (levels 3 and 4), are so circumscribed.  Inflammatory cells, 
mostly  lymphocytes,  are  i~adicated by open  circles  and  are  concentrated  about  blood  vessels. 
Damaged endothelial cells are colored  black.  Dyskeratotic  foci of epidermis and accompanying 
inflammatory  cells (not separately indicated) are also indicated in black. Infarction of the graft after 
day 10 is designated by cross-hatching. 
A  finding described  in guinea pig allografl  rejection  (31),  but one not previously 
appreciated  in  human  skin  grafts,  is  that  basophilic  leukocytes  also  participated 
prominently  in  the  cellular  infiltrate,  appearing  initially in  the  same  perivascular 
distribution  as  lymphocytes,  but  several  days  later  (Fig.  2 C,  D).  In  contrast  to 
lymphocytes,  the  majority  of  basophils  did  not  persist  about  venules  but  rather 
became  disseminated  through  the  graft  dermis  and  occasionally infiltrated the  epi- 326  REJECTION OF  FIRST-SET SKIN ALLOGRAFTS IN MAN 
dermis as well.  Basophils became increasingly  numerous  in  allografts a  day or two 
before rejection, accounting for up to 5% of infiltrating cells.  Basophils underwent  a 
form of piecemeal degranulation  (Fig. 2 C)  as previously described in contact allergy 
(32). Eosinophils were also sometimes present in small numbers (33) but they appeared 
sporadically and only after the infiltration of basophils. DVORAK,  MIHM,  DVORAK,  BARNES, MANSEAU, AND GALLI  327 
For the  most  part,  graft  epithelial  elements  appeared  normal  and  were  indistin- 
guishable  from their  counterparts  in  autografts  through day 9  or  10.  However,  the 
epidermis  and  especially  the  hair  follicles did  exhibit  scattered  foci  of dyskeratosis 
(individual cell necrosis) and intercellular edema accompanied by a localized cellular 
infiltrate  composed mostly of lymphocytes but  also including neutrophils  and occa- 
sionally basophils.  Such areas  of dyskeratosis  never involved >5-10%  of the epithe- 
lium. 
MICROVASCULAR ALTERATIONS ACCOMPANYING CELLULAR INFILTRATE.  The microvas- 
culature  of both  the  allograft  and  the  graft  bed  exhibited  identical  and  striking 
alterations which were particularly evident  in those venules and arterioles enveloped 
by cuffs of lymphocytes (Fig.  1, levels 2-4; Figs. 2 A-C, 3, 4). As in contact allergy (26, 
27),  pericytes  and  endothelial  cells  at  all  levels appeared  activated  (hypertrophied) 
and  frequently exhibited  mitoses;  hypertrophied  endothelial  cells sometimes  bulged 
into,  and  apparently  compromised,  vascular  lumens  (Figs.  2 B,  C;  3A-E,  H,  I;  4). 
However, the most striking new finding was the concomitant  development  of wide- 
spread  and progressive endothelial  cell  injury  (Figs. 3C-F, L J; 4).  Microscopic and 
ultrastructural  evidence of injury was evident shortly after the appearance of perivas- 
cular  lymphocyte cuffs  (days  5-6)  and  included  endothelial  cell  swelling and  cyto- 
plasmic lucency; membrane swelling, blebbing, and disruption; nuclear pyknosis; and 
focal sloughing of entire endothelial cells, permitting exposure of circulating elements 
to the vascular basement membrane.  Endothelial cell damage was often accompanied 
by edematous thickening of the basement membrane zone (V1, Fig. 3 D). 
In contrast  to contact dermatitis,  where analogous microvascular injury was rela- 
tively slight  and self-limited  (26,  27), endothelial  cell  damage in  allografts was well 
developed by day 6 and became increasingly prominent with the passage of time and 
progression of the cellular infiltrate  (Table II). By day  10, the vast majority of vessel 
profiles counted exhibited  necrosis of at  least  some endothelial  cells.  Both vessels of 
the graft and recipient graft bed were affected but level-2 and -3 vessels were generally 
damaged earlier and more extensively than those in levels  1 and 4. In addition, many 
vessel  lumens  were  dramatically  narrowed  or  even  occluded  by  encroachment  of 
activated,  or damaged  and  swollen,  endothelial  cells.  In some instances,  vessels  lost 
their normal organization altogether and appeared  as clusters of viable or damaged, 
but  still  identifiable  (by electron  microscopy), endothelial  cells  without  relation  to 
any recognizable lumen.  Larger arteries  and  veins  (Diam  >50/tm)  of the graft  bed 
were generally less severely injured but were occasionally infiltrated with lymphocytes 
or basophils  (Fig.  3 G).  By day  10,  thrombosis  developed  in some graft  vessels  (Fig. 
Fte.  2.  A. 8-d allograft exhibiting extensive perivascular inflammatory cell infiltration at level 2 
of graft and levels 3 and 4 of graft bed. Arrows indicate the graft-graft bed junction which is marked 
by trace fibrin deposits (not visible at this low magnification) and by a hair follicle. Proliferation of 
hair follicle epithelium in the graft-graft bed junction was commonly observed in allografts, but not 
in autografts. There is focal hemorrhage but little lymphocyte infiltration in the superficial graft 
dermis and  the epidermis appears  intact. B.  Perivascular infiltrate,  nearly all  lymphocytes and 
lymphoblasts, surrounding level-2 allograft vessels. Note hypertrophied endothelial cells of vessels 
(V)  and  interstitial  hemorrhage (H). C.  Dermis of graft bed reveals a cellular infiltrate rich in 
basophils (arrows), some of which exhibit nearly complete degranulation (open arrows). Venule (V) 
shows striking endothelial cell activation. D. Electron micrograph of infiltrating dermal basophil 
with generally good particle content in cytoplasmic granules. N, nucleus; Gly, glycogen. A-C, l-.ttm- 
thick, Giemsa-stained Epon sections. A,  ×  50; B,  ×  315; C,  ×  650. D, electron micrograph,  x 
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5B)  as  has  been  described  by  others  (1,  19),  but  the  lumens  of graft-bed  vessels 
generally remained free of fibrin clots despite extensive endothelial cell injury. 
The physiologic significance of these vessel  changes was manifest as early as day 5 
by the leakage of plasma from vessels,  leading to tissue edema and fibrin deposition DVORAK,  MIHM,  DVORAK,  BARNES,  MANSEAU, AND GALLI  329 
FlG. 4.  Electron  micrograph of a typical venule from an 8-d allograft exhibiting both endothelial 
cell activation (E) and necrosis (NE). Vessel is cuffed by small lymphocytes  (Ly).  ×  6,500. 
that  was  appreciated  microscopically and clinically as swelling and  induration  (26, 
34). After day 7, more extensive vessel damage permitted the progressive extravasation 
of erythrocytes (Figs. 2 A, B); in advantageous sections, sites of extravasation could be 
localized to areas of endothelial damage.  Extensive hemorrhage into the graft  dermis 
was  common  by  day  9  or  10  (Fig.  5A).  These  changes,  which  are  consistent  with 
marked  diminution or cessation of local  blood  flow,  generally preceded  widespread 
necrosis of graft epithelial elements by 24-48 h. 
GRAFT REJECTXON.  The  final phase  of the  graft  rejection  process  consisted of the 
relatively  sudden  (within  1-2  d)  necrosis  of scattered  islands  of graft  tissue;  these 
islands initially measured up to  1 cm in largest  diameter but coalesced over 24-48 h 
to involve most of the graft. Microscopically, such areas exhibited coagulation necrosis 
FIG.  3.  Microvascular endothelial cell activation and necrosis in allografts  undergoing immuno- 
logic rejection. Activated endothelium (AE) was identified in vessels of both the graft  (B) and the 
graft  bed (A, E). Vascular lumens were sometimes extensively compromised by activated endothe- 
lium, seen compressing an intraluminal  eosinophil  (e) in A and several lymphocytes (double-headed 
arrow) in B. The endothelium of both venules (V) and arterioles  (A) of the graft  ((3) and graft bed 
(D-b,/,J), exhibited injury as indicated by swollen, lucent ghost-like cell remnants (V~ and V3, D) 
or by ragged loss of endothelium (V2 in D; NE in E, F). Altogether  necrotic vessels were commonly 
observed  at later intervals (Nv, J).  The walls of larger venules and veins were not uncommonly 
infiltrated by basophils  (arrows)  or lymphocytes  (open  arrow)  as  in G. All  l-p.m-thick, Giemsa- 
stained Epon sections. A, C, G J,  x  645; B, E, F,  x  1,000; D,  X 790. 330  REJECTION  OF  FIRST-SET  SKIN  ALLOGRAFTS  IN  MAN 
TABLE  II 
Quantitative Evidence of Progressive Microvascular Injury Preceding First-Set Skin A llograft Rejection 
Number of vessel profiles counted 
Percentage of vessel  profiles exhibiting  necrotic endo- 
thelium 
Vessel level  AIIografts  Autografts  AIIografts  Autografts 
Day  Day  Day  Day  Day 6  Day 8  Day 6  Day 8  Day 6  Day 8  Day 6  Day 8  10  10  10  10 
'7,  ,/, 
1 Papillary  dermis,  146  158  150  --  28  37  30.8  42.4  76.6  I  0  2.7 
graft 
2 Deep  dernds,  graft  198  307  216  --  41  87  41.4  59.6  82.4  --  2.4  2.3 
3 Dermis,  graft bed  89  197  277  --  31  62  45.0  65.5  79.8  --  3.2  0 
4 Subcuds,  graft bed  41  99  98  --  7  67  34.1  40.4  45.9  --  0  0 
Total  474  761  741  107  253 
Biopsies  of 6-, 8-, and 10-d allografts from all eight recipients  were studied in I-/~m Epon sections.  This technique  permitted positive  vessel 
identification  and evaluation.  All vt~sels  encountered  at the four levels  defined  in Fig. I were  scored  for the presence  of damaged  endothelium. 
Data are expressed  as the total numbers of vessel profiles  encountered  and the percentage  of these that exhibited  one or more necrotic 
endothelial cell. 8- and 10-d  autografts  from three  recipients  were  similarly  assessed.  Chl-squatv  analysis  revealed  that in every instance  (days 
8 and 10. vessel  levels 1 4) allograft vessels  exhibited  significantly  more  endothelial  necrosis  than corresponding  autografts (P< 0.005). 
of  the  entire  thickness  of  the  graft  including  epidermis,  appendages,  vessels,  and 
inflammatory  cells (Fig. 5 B), and  thus resembled  tissue undergoing  ischemic infarction 
in  other  clinical  settings  following  cessation  of  local  blood  flow  (e.g.,  myocardial 
infarction).  While  necrosis was largely confined  to the graft itself, contiguous  portions 
of the  superficial  graft  bed  (tissue of recipient  origin)  were  sometimes  also  damaged 
(Fig.  5 B). 
The  relatively  sudden  rejection  episode  could  not  be  explained  by  individual, 
persistent  anatomic  contacts  between  graft-epithelial  elements  and  any  type  of 
inflammatory  cell. Damage  to epithelial  cells in dyskeratotic  foci of the epidermis  and 
appendages  was  associated  with  infiltrating  lymphocytes  and  was evident  as early as 
day  5.  However,  this  process  progressed  slowly,  and  even  at  the  time  of rejection 
involved  <5-10%  of the epithelium. 
Microscopic  Appearance  of Autografts.  Healing  of autografts  resembled  that  of allo- 
grafts until  approximately  day  5.  Thereafter,  the vessel activation  that  accompanied 
revascularization  of autografts  ceased  and  perivascular  mononuclear  cell  infiltrates 
and  associated  vascular  endothelial  cell necrosis never  appeared  in either the graft or 
the graft bed. Free autografts  differed from skin flap autografts  only in that  they were 
slower  to  acquire  a  vascular  supply  and  developed  transient  early  foci  of epithelial 
injury.  By days  10-1 1,  all autografts  were well healed  with  a  patent  microvasculature 
and  healthy-appearing  epidermis  and  appendages  (Fig.  5 C, D). 
FIG.  5.  A. 9-d allograft exhibiting perivascular lymphocytic infiltrate, interstitial hemorrhage (H), 
but an as-yet intact epidermis. B.  1  l-d allograft exhibiting characteristic pattern of infarction. The 
now  desiccated  graft  has  lost  more  than  one-half of its  vertical  dimension  (compare  with  A, 
photographed at  nearly the same magnification) and is characterized by a  necrotic epidermis (E) 
and  prominent, dilated, and thrombosed blood vessels (DV). Arrows mark junction of graft and 
graft  bed.  Fibrin  deposits are  abundant  at junction  and  also extend  into  the  graft  bed,  upper 
portions of which also appear necrotic. C and D.  10-d  autografts illustrating satisfactory healing, 
absent inflammatory cell infiltrate, and healthy blood vessels. Junction of graft and graft bed in C, 
indicated by arrows, is not readily discernible. All  1-btm-thick, Giemsa-stained Epon sections. A,  × 
125; B,  ×  160; C,  ×  30;  D,  X  500. DVORAK, MIHM, DVORAK, BARNES, MANSEAU, AND GALLI  331 
Immunofluorescence Studies.  Tissue from allografts and autografts was examined by 
immunofluorescence at  6-10  d  after  grafting.  The  graft-graft  bed  interface  was 
characterized by brilliant-staining fibrinogen/fibrin deposits in all biopsies studied. 
Although the antisera employed stained both fibrinogen and fibrin, deposits could be 332  REJECTION OF FIRST-SET SKIN ALLOGRAFTS IN MAN 
identified as fibrin in most instances at high magnifications by virtue of their fibrillar 
structure.  In  autografts  after  day  8,  fibrin  deposits  were  less  extensive  than  in 
corresponding  allografts,  apparently  reflecting  more-complete  healing  and  fibrin 
resorption in the former. Only trace quantities of fibrin were deposited elsewhere in 
autografts  or  in  autograft  beds.  However, moderate  to  extensive  (1 +-4+)  fibrin 
deposits were regularly observed in  the  intervascular portions of the  graft  beds  of 
allografts, extending in  some instances  into the subcutaneous  tissue.  Less-extensive 
but similar deposits were observed in  intervascular portions of the allografts them- 
selves.  This pattern of fibrin deposition is identical to that which has been described 
in  delayed  hypersensitivity skin  reactions  (26,  34).  In  addition,  thrombosed  graft 
vessels in  10-d allografts stained intensely with anti-fibrinogen/fibrin antibodies. 
Staining  of both allografts  and  autografts  with  anti-gamma  globulins  and  anti- 
human albumin antibodies was entirely negative. Occasional vessels in both allografts 
and  autografts,  and  their  respective graft  beds,  stained  with  anti-C'3,  but  in  the 
absence  of associated  immunoglobulin  deposition,  this  is  a  nonspecific  finding  of 
unknown significance. 
Discussion 
The principal new findings are (a) that the extensive epithelial necrosis characteristic 
of first-set skin allograft rejection was invariably preceded by widespread microvas- 
cular damage, particularly affecting the lymphocyte-enveloped venules and arterioles 
of both the deep dermis of the allograft and the contiguous, superficial graft bed and 
(b) that the pattern of allograft rejection resembled that of infarction, with extensive 
microvascular damage and associated greatly increased vascular permeability leading 
to edema, local hemorrhage, stasis of blood flow, and aliograft death due to ischemia. 
Autografts exhibited neither these vascular changes nor their consequences. It seems 
probable,  therefore, that  the microvasculature is the critical target of immunologic 
damage in first-set skin allografts exchanged among immunologically intact, randomly 
selected humans. Recent studies of allograft rejection across strong H-2 barriers in the 
mouse (S. J. Galli, H. J. Winn, and H. F. Dvorak. Manuscript in preparation.) have 
revealed a similar pattern of microvascular injury and ischemic infarction, indicating 
that  the findings reported here are not peculiar to a  single species. Whether similar 
events accompany the more chronic forms of rejection associated with weaker histo- 
compatibility differences or immunosuppression remains to be determined. 
The concept that first-set skin allografts may be destroyed by a process of ischemic 
infarction is entirely consistent with the well-known observation, here confirmed, that 
allograft  rejection  across  strong  histocompatibility  barriers  occurs  as  a  relatively 
sudden event characterized by total and virtually simultaneous necrosis within 24-48 
h  of all graft and inflammatory cell elements throughout the entire thickness of the 
graft.  Such  a  pattern  of rejection can  best  be explained on  a  vascular  basis.  The 
concept is also consistent with the careful and frequently overlooked studies of such 
early workers as Taylor and Lehrfieid (35), Converse and Rappaport (36), and Zarem 
(37), who undertook direct microscopic examination of living grafts in intact animals 
or  man.  Lacking  the  resolution  afforded  by  modern  sectioning  techniques,  these 
authors were not able to define endothelial cell injury or the nature of graft necrosis 
but did document an initial phase of graft hyperemia followed by endothelial swelling, 
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Our findings render less tenable an alternate hypothesis, that allografts are rejected 
primarily as the result of piecemeal and progressive cytotoxic damage to individual 
epidermal  and  other epithelial  cells  caused  by contacts  or close  associations  with 
infiltrating inflammatory cells.  Although  scattered lymphocytes and  basophils  mi- 
grated into the graft epidermis and skin appendages, their infiltration appeared to be 
associated with only focal damage to epithelial cells that could not have accounted 
for  the  sudden  and  nearly  simultaneous  necrosis  of  the  full  thickness  of  these 
vascularized skin grafts. 
Despite widespread  vascular  injury, intravascular thrombi  were noted only as  a 
late event and predominantly affected graft vessels. Even though the focal endothelial 
cell damage exhibited by deeper graft bed vessels would have been expected to trigger 
clotting  (38),  thrombosis  of such  vessels  was  only  observed  rarely.  Graft  vessel 
thrombosis may have contributed to the infarction of allografts. However, it should 
be remembered that thrombosis is a variable event in clinical situations that involve 
ischemic infarction of tissue and is not itselfa necessary prerequisite for ischemic tissue 
death. 
Although the microvasculature can now be regarded as the critical target in first- 
set human skin allograft rejection, the mechanisms by which vascular endothelium is 
damaged  remain  to  be  established.  Of critical  importance  to  this  question  is  the 
observation that vessels of both the allograft (presumably of donor origin) and of the 
graft bed (presumably of host origin) underwent equal and progressive damage. This 
finding  suggests  that  the  final  events  in  first-set  skin  allograft  rejection  are  not 
immunologically specific.  Members  of the  lymphocyte series represent  the  likeliest 
candidates for the role of effector cells, partly because of their dominant numbers, but 
also because of their striking anatomic distribution, enveloping many graft and graft 
bed  vessels.  Several  mechanisms  have  been  described  by which  lymphocytes may 
destroy  foreign  target  cells  (14).  If indeed  lymphocytes are  responsible  for  vessel 
damage, a cytotoxic mechanism that does not require direct and persistent anatomic 
contacts may be implicated because, except during diapedesis, endothelial cells were 
separated from enveloping inflammatory cells by the vascular basement membrane 
and sometimes by perivascular collagen as well. Secretion of a  diffuseable mediator 
selectively  toxic  for  endothelial  cells  (both  donor  and  host)  represents  a  likely 
possibility and  the susceptibility of endothelial cells to known  lymphokines such as 
lymphotoxin deserves investigation.  A  role for basophils  is also  possible because of 
their accumulation in the days immediately preceding graft rejection and their known 
capacity to secrete vasoactive mediators such as  histamine.  Monocytes and  macro- 
phages, present in small numbers, might also be implicated. Graft recipients lacked 
demonstrable antibodies against donor-lymphocyte HLA antigens and immunoglob- 
ulin deposits were not observed in vessel walls or elsewhere in rejecting allografts by 
immunofluorescence, findings that argue against a role for cytotoxic antibodies in the 
rejection process. 
Two objections may be raised to the scheme of allograft rejection proposed here. 
The first is that many of the morphologic features of allograft rejection closely mimic 
those of delayed hypersensitivity reactions where epithelial necrosis is not a  regular 
feature. We have recently demonstrated, however, that delayed skin reactions elicited 
with  purified proteins or defined haptens  invariably exhibit  vascular  damage  and 
repair (26,  27). As long as repair keeps pace with injury, tissue necrosis is unlikely to 334  REJECTION OF FIRST-SET SKIN ALLOGRAFTS IN MAN 
occur, particularly in  an  organ as well endowed with  vascular anastomoses  as  the 
skin.  More severe injury to the  microvasculature,  as  may occur in  allografts  for a 
variety of reasons (e.g.,  more prolonged antigen stimulation, qualitative or quantita- 
tive differences in the pattern of lymphocyte mediator secretion, etc.), may overwhelm 
reparative processes, leading to vascular death and stasis of blood flow. In support of 
this argument, it is well known that severe tuberculin and other delayed hypersensi- 
tivity reactions in man and animals exhibit central necrosis; studies of such reactions 
in the guinea pig reveal a pattern of widespread microvascular damage and cutaneous 
infarction similar to that observed here (H. F. Dvorak, unpublished data). 
A second objection concerns the specificity of allograft rejection. Our data suggest 
that skin allograft rejection, though induced by immunologically specific mechanisms, 
is primarily effected by final pathways that damage both foreign and host vessels and 
cells.  Apparently contrary to these  findings,  other investigators have found a  high 
level of specificity in the immunologic rejection of vascularized allografts. Billingham 
et al.  (6),  Billingham and Silvers (39, 40)  and Mintz and Silvers (41, 42) employed 
donor grafts composed of a mixture of genetically compatible and incompatible cells; 
compatible cells were commonly pigmented melanocytes that could later be positively 
identified  in  the  recipient.  In  these  experiments,  at  least  some  compatible  cells 
generally survived as judged by the persistence of pigmented skin and hair after the 
rejection of incompatible,  nonpigmented skin.  Similar experiments have been  per- 
formed with mixtures of compatible and incompatible epidermal cells and tumor cells 
with both similar (6, 43) and contradictory (6, 44) results. Critical examination of the 
published data indicates that they are, in fact, reconcilable with those presented here. 
Survival of compatible pigment cells in an otherwise incompatible graft may result 
from  migration  of such  cells  from  the  epidermis  or superficial  hair  follicles of the 
donor skin to the transected hair follicles of the recipient in the graft bed (45). Because 
melanocytes are capable of extensive replication as well as migration, survival of only 
a small fraction of grafted compatible cells could permit the retention of substantial 
pigmented skin  and  hair after allograft  rejection by a  vessel-damaging mechanism 
that  did  not  itself discriminate  between  foreign and  compatible  endothelial  cells. 
Further, Mintz and Silvers (41, 42) found that genetically comPatible portions of skin 
grafts generally did undergo nonspecific rejection if foreign cells comprised a majority 
of the donor graft. Finally, we do not contend that microvascular damage leading to 
infarction  is  the  only  immunologic  mechanism  for  rejecting  foreign  cells.  Clearly 
allogeneic cells can be destroyed in a  highly specific and discriminating fashion by 
direct cell contact with cytotoxic lymphocytes or by specific antibodies (14). Although 
evidence for anti-HLA antibodies was lacking in the present experiments, scattered 
lymphocytes  did  infiltrate  graft  epidermis  and  appendages  and  very  likely  were 
responsible for the focal epithelial cell dyskeratosis observed after day 5; however, the 
contribution of this process to graft rejection appeared to be minor. Nonetheless, such 
an immunologically specific lymphocyte-contact mechanism very likely accounts for 
the highly selective rejection of incompatible melanoblasts admixed within single hair 
follicles in grafts of allophenic mouse skin to parental strains (41, 42). 
In  summary,  allograft  rejection may involve both  highly  specific and  relatively 
nonspecific mechanisms operating separately or together, depending on such factors 
as  the  nature  and  antigenicity of the  graft,  its  location,  and  whether or not  it  is 
vascularized.  Species  variation  may  also  play  a  role  in  the  pattern  of allograft DVORAK, MIHM, DVORAK, BARNES, MANSEAU, AND GALLI  335 
rejection. That the destruction of foreign cells may be effected by multiple mechanisms 
is not surprising in view of the well-known heterogeneity of the immune response to 
relatively simple and better-defined antigens. 
Summary 
Recent reports of microvascular injury in delayed hypersensitivity skin reactions 
prompted us to reexamine the pathogenesis of first-set skin allograft rejection in man 
using  morphologic  techniques  that  allowed  both  extensive  vessel  sampling  and 
unequivocal  evaluation  of microvascular endothelium.  We  here report  that  wide- 
spread  microvascular damage  is  a  characteristic, early consequence of the cellular 
immune response to first-set human skin allografts and isqualitatively similar to, but 
substantially more extensive than, that occurring in delayed hypersensitivity reactions. 
Microvascular damage invariably preceded significant epithelial necrosis and affected 
initially and  primarily those venules, arterioles, and small  veins enveloped by lym- 
phocytes. Vessels of both the allograft itself and the underlying graft bed (recipient 
tissue) were equally affected. These data suggest that  endothelial cells of the micro- 
vasculature are the critical target of the immune response in first-set vascularized skin 
allograft  rejection in  man  and  that  rejection can be attributed  largely to ischemic 
infarction resulting from extensive microvascular damage. Other mechanisms, such 
as direct cellular contacts between infiltrating lymphocytes and epithelium, appar- 
ently played only a minor role. 
The findings presented here indicate that the rejection of first-set vascularized skin 
allografts,  though  induced  by  immunologically  specific  mechanisms,  is  primarily 
effected by final pathways that are relatively nonspecific and that may cause damage 
to both foreign and host vessels  and cells. Rather than contradicting studies demon- 
strating the exquisite specificity of allograft rejection in other systems, these findings 
provide  a  further  example  of the  heterogeneity of the  cellular  immune  response. 
Recognition of the critical  role of immunologically mediated  microvascular injury 
may prove important both for an understanding of the biology of allograft rejection 
and for strategies aimed at prolonging allograft survival. 
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